Fluarix Tetra

The Fluarix Tetra injection is a quadrivalent influenza vaccine aimed at providing protection against four strains of the influenza virus: two subtypes of Type A (H1N1 and H3N2) and two lineages of Type B.

The Fluarix vaccine is essential in preventing influenza, especially for high-risk groups such as the elderly, young children, pregnant women, and those with chronic health issues. Even if vaccinated individuals do contract the flu, the vaccine can lessen the severity and duration of symptoms, thus reducing the risk of serious complications and hospitalization.

By enhancing vaccination rates in communities, the transmission of influenza can be greatly reduced, benefiting public health. However, it is crucial to take individual health histories into account, as some individuals may experience allergic reactions to components of the vaccine, particularly egg proteins. Those with a history of severe allergic reactions or Guillain-Barré syndrome should seek advice from a healthcare provider prior to vaccination. The Fluarix Tetra vaccine is authorized for individuals aged 6 months and older, making it an important option for safeguarding both children and adults against the flu.